References
- Organisation WH. Epilepsy fact sheet. New York World Health Organization; 2018. Available from: http://www.who.int/mediacentre/factsheets/fs999/en/
- Scharfman HE. The neurobiology of epilepsy. Curr Neurol Neurosci Rep. 2007;7(4):348–354.
- Fisher RS. The new classification of seizures by the international league against epilepsy 2017. Curr Neurol Neurosci Rep. 2017;17(6):48.
- Nevitt SJ, Sudell M, Weston J, et al. Antiepileptic drug monotherapy for epilepsy: a network Meta‐analysis of individual participant data. Cochrane Database Syst Rev. 2017;6:CD011412.
- Boon P, Ferrao Santos S, Jansen AC, et al. Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update. Acta Neurol Belg. 2021;121(1):241–257.
- Chen Z, Brodie MJ, Liew D, et al. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA Neurol. 2018;75(3):279–286.
- Schiller Y. Seizure relapse and development of drug resistance following long-term seizure remission. Arch Neurol. 2009;66(10):1233–1239.
- Kwan P, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies; 2010. Wiley Online Library.
- Laxer KD, Trinka E, Hirsch LJ, et al. The consequences of refractory epilepsy and its treatment. Epilepsy Behav. 2014;37:59–70.
- Jansen C, Francomme L, Vignal J-P, et al. Interictal psychiatric comorbidities of drug-resistant focal epilepsy: prevalence and influence of the localization of the epilepsy. Epilepsy Behav. 2019;94:288–296.
- Jacoby A, Snape D, Baker GA. Epilepsy and social identity: the stigma of a chronic neurological disorder. Lancet Neurol. 2005;4(3):171–178.
- Jacoby A, Baker G. Quality of life issues in intractable focal epilepsy. In: Intractable focal epilepsy. London: WB Saunders; 2000. p. 419–436.
- W.H.O. The Global Burden of Disease: 2004 Update. Available at: http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf; 2018.
- Society E. Caring for someone with epilepsy; 2019. Available from: https://wwwepilepsysocietyorguk/caring-someone-epilepsy.
- Brouwer WBF, van Exel NJA, van den Berg B, et al. Process utility from providing informal care: the benefit of caring. Health Policy. 2005;74(1):85–99.
- Kanters TA, Brugts JJ, Manintveld OC, et al. Burden of providing informal care for patients with atrial fibrillation. Value Health. 2021;24(2):236–243.
- NICE, Guide to the methods of technology appraisal; 2013. Available from: https://wwwniceorguk/process/pmg9/chapter/the-reference-case#measuring-and-valuing-health-effects.
- Al-Janabi H, Nicholls J, Oyebode J. The need to “carer proof” healthcare decisions. 2016. British Medical Journal Publishing Group.
- Devlin NJ, Brooks R. EQ-5D and the EuroQol group: past, present and future. Appl Health Econ Health Policy. 2017;15(2):127–137.
- Hoefman RJ, van Exel NJA, Foets M, et al. Sustained informal care: the feasibility, construct validity and test-retest reliability of the CarerQol-instrument to measure the impact of informal care in long-term care. Aging Ment Health. 2011;15(8):1018–1027.
- Brouwer WBF, van Exel NJA, van Gorp B, et al. The CarerQol instrument: a new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations. Qual Life Res. 2006;15(6):1005–1021.
- Reilly MC, Gooch KL, Wong RL, et al. Validity, reliability and responsiveness of the work productivity and activity impairment questionnaire in ankylosing spondylitis. Rheumatology. 2010;49(4):812–819.
- Hoefman RJ, van Exel J, Brouwer WB. Measuring care-related quality of life of caregivers for use in economic evaluations: CarerQol tariffs for Australia, Germany, Sweden, UK, and US. Pharmacoeconomics. 2017;35(4):469–478.
- Szende A, Janssen B, Cabases J. Self-reported population health: an international perspective based on EQ-5D. 2014. Springer Nature.
- Van den Hout W. The value of productivity: human-capital versus friction-cost method. Ann Rheumatic Dis. 2010;69(Suppl 1):i89–i91.
- Explained ES. Wages and labour costs; 2019. Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php/Wages_and_labour_costs#Net_earnings_and_tax_burden
- Action E. Epilepsy facts and terminology; 2018. Available from: https://www.epilepsy.org.uk/press/facts
- Schmitz B, Montouris G, Schäuble B, et al. Assessing the unmet treatment need in partial-onset epilepsy: looking beyond seizure control. Epilepsia. 2010;51(11):2231–2240.
- Harden CL, Maroof DA, Nikolov B, et al. The effect of seizure severity on quality of life in epilepsy. Epilepsy Behav. 2007;11(2):208–211.
- Hussain SA, Ortendahl JD, Bentley TGK, et al. The economic burden of caregiving in epilepsy: an estimate based on a survey of US caregivers. Epilepsia. 2020;61(2):319–329.
- Lai S-T, Tan W-Y, Wo MC-M, et al. Burden in caregivers of adults with epilepsy in Asian families. Seizure. 2019;71:132–139.
- Andel J, Westerhuis W, Zijlmans M, et al. Coping style and health-related quality of life in caregivers of epilepsy patients. J Neurol. 2011;258(10):1788–1794.
- Jiang R, Shaw J, Mühlbacher A, et al. Comparison of online and face-to-face valuation of the EQ-5D-5L using composite time trade-off. Qual Life Res. 2021;30(5):1433–1444.
- Rowen D, Brazier J, Keetharuth A, et al. Comparison of modes of administration and alternative formats for eliciting societal preferences for burden of illness. Appl Health Econ Health Policy. 2016;14(1):89–104.
- Norman R, King MT, Clarke D, et al. Does mode of administration matter? Comparison of online and face-to-face administration of a time trade-off task. Qual Life Res. 2010;19(4):499–508.
- Dillman DA. Why choice of survey mode makes a difference. Public Health Rep. 2006;121(1):11–13.